The Ireland Strategic Investment Fund (“ISIF”) has co-invested €15m in Chanelle Pharma through an Exponent-managed co-investment vehicle.
Chanelle Pharma is the largest indigenous pharmaceutical company in Ireland and a leading manufacturer of generic veterinary and medical pharmaceutical products.
Exponent is an established private equity firm with a track record of successfully investing in and growing founder-led and corporate owned businesses across Europe and Ireland.
The investment aligns with ISIF's Scaling Indigenous Businesses impact theme and supports the continued growth of a large Galway-headquartered business.